Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002999:Clone Cells / Q000187:drug effects; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011239:Prednisolone / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate